Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial] is to learn about the effect of methylphenidate in children and adolescents with KBG syndrome. The main question it aims to answer is: • What is the effectiveness of methylphenidate on attention deficit and ADHD-related symptoms in children and adolescents with KBG syndrome? Participants will receive multiple blocks of treatment with methylphenidate and placebo and fill out various questionnaires.


Clinical Trial Description

KBG syndrome (KBGS) is a neurodevelopmental disorder (NDD) characterized by developmental delay and/or intellectual disability, typical facial features, skeletal and congenital anomalies. Behavioural issues are a frequent feature, reported in 50-94% of persons with KBGS.The behavioural problems are diverse, and include attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), obsessive-compulsive disorder, anxiety, and difficulties in social situations. Van Dongen et al. systematically investigated the behavioural and cognitive phenotype of KBGS patients. This study showed a high level of distractibility, impulsivity and restless behaviour in KBGS patients. As a tertiary reference centre for KBGS in the Netherlands, the investigators notice there is an unmet need for evidence-based interventions for the behavioral problems related to KBGS. A previous survey amongst KBGS caretakers confirmed that (features of) attention-deficit/hyperactivity disorder (ADHD) are the most frequently reported behavioural problems in children with KBGS. Furthermore, the study results indicate that methylphenidate (MPH) has a good effect on ADHD-related symptoms in KBGS, as this is reported by most parents. The promising results from this first exploration on MPH in KBGS indicate that it seems even more effective than in the general population of children with ADHD. However, evidence-based data on optimal dosing and adverse events are lacking. Remarkably, only 2/12 KBGS patients who were treated with stimulants such as MPH had an official ADHD diagnosis. This indicates that patients with ADHD-related symptoms fitting with a probability diagnosis of ADHD, but who do not necessarily fit all the Diagnostic and statistical manual 5 (DSM-5) criteria for ADHD, may also benefit from drug treatment. The investigators will examine the effectiveness of MPH in children and adolescents with KBGS and (a probability diagnosis of) ADHD, using an N-of-1 series (aggregated N-of-1) trial design. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06465641
Study type Interventional
Source Radboud University Medical Center
Contact Charlotte Ockeloen, MD
Phone +31243613946
Email charlotte.ockeloen@radboudumc.nl
Status Not yet recruiting
Phase Phase 4
Start date September 1, 2024
Completion date October 1, 2027

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Completed NCT04799886 - Attitudes Associated to Prescription of ADHD Drugs Among Child and Adolescent Psychiatrists in Region Skåne.
Completed NCT04511169 - MyADHD-digital Training for Adults With ADHD N/A
Completed NCT05452954 - Psychosocial ADHD Interventions - Brief Parent Training N/A
Recruiting NCT03313349 - A School-Based Intervention to Improve Social Functioning N/A
Completed NCT01727414 - Attention Deficit Disorder Medication Response Study Phase 4
Active, not recruiting NCT05930912 - Psychiatric Orders in Psychoanalytic Treatment of ASD
Recruiting NCT05924594 - Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301 Phase 3
Recruiting NCT04781972 - Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD Phase 4
Active, not recruiting NCT05286762 - Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 Phase 3
Not yet recruiting NCT06235177 - Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues Early Phase 1
Recruiting NCT04504890 - Ocular-vestibular Biomarker Identification for ADHD
Recruiting NCT06299189 - A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care N/A
Recruiting NCT04729439 - Technology-Enhanced Executive Functioning Intervention for ADHD Phase 1
Completed NCT03335748 - the Cogmed Program for Youths With ADHD N/A
Completed NCT05631626 - Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301. Phase 3